Preclinical data of rabbits having convulsions has prompted the U.S. FDA to place a clinical hold on Neumora Therapeutics Inc.’s phase I study of NMRA-266 in healthy adults. Neumora said about 30 ...
BOSTON and SAN DIEGO, April 21, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and ...
The convulsions experienced in rabbits have not been reported in any of the 30 humans who have so far received NMRA-266. (Maya23K/iStock/Getty Images Plus) The FDA has placed a phase 1 trial of ...
Patient screening for the Phase 2a study is expected to begin by the first quarter of 2027; Filana has engaged a leading ...
A first seizure in adulthood is a common reason for emergency department evaluation and subsequent follow-up in primary care. Family physicians are often responsible for confirming the diagnosis, ...
Absence seizure, formerly known as petit mal seizure, is a type of short seizure that usually causes a person to briefly lose focus, stare into space, and lose awareness of their surroundings. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results